PMID- 15263066 OWN - NLM STAT- MEDLINE DCOM- 20041215 LR - 20131121 IS - 0022-3565 (Print) IS - 0022-3565 (Linking) VI - 311 IP - 1 DP - 2004 Oct TI - Chronic morphine treatment alters N-methyl-D-aspartate receptors in freshly isolated neurons from nucleus accumbens. PG - 265-73 AB - Although there is now evidence of a role for N-methyl-D-aspartate (NMDA) receptors in nucleus accumbens (NAcc) neurons in the effects of chronic opiate treatment, the cellular and molecular mechanisms underlying this phenomenon are still unclear. Therefore, we studied the effects of chronic morphine on the pharmacological and biophysical properties of NMDA receptors in freshly isolated medium spiny neurons from NAcc. We found that chronic morphine treatment did not alter the affinity for NMDA receptor agonists such as glutamate, homoquinolinic acid, and NMDA, but decreased the affinity of glycine, the allosteric NMDA receptor coagonist, from 2.24 +/- 0.15 microM to 5.1 +/- 1.45 microM. Chronic morphine treatment also altered the affinity of two noncompetitive NMDA receptor antagonists, 7-chloro-kynurenic acid and ifenprodil. However, morphine had no effect on a third antagonist, D-(-)-2-amino-5-phosphonopentanoic acid. Single-exponential fits of desensitized NMDA current tails gave tau values ranging from 0.5 to 4 s in neurons from both control and morphine-treated rats. However, a shift to the left of the distribution of tau values after morphine treatment revealed that NMDA current desensitization rate was accelerated in a majority of NAcc neurons. Taken together with our recent molecular studies, our data are consistent with a shift away from NMDA receptor subunit (NR) NR2B and 2C function toward increased NR2A subunit expression or function after chronic morphine, a process that could alter excitability and integrative properties and may represent a neuroadaptation of NAcc medium spiny neurons underlying morphine dependence. FAU - Martin, Gilles AU - Martin G AD - Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA, USA. gilles.martin@umassmed.edu FAU - Guadano-Ferraz, Ana AU - Guadano-Ferraz A FAU - Morte, Beatriz AU - Morte B FAU - Ahmed, Serge AU - Ahmed S FAU - Koob, George F AU - Koob GF FAU - De Lecea, Luis AU - De Lecea L FAU - Siggins, George R AU - Siggins GR LA - eng GR - AA06420/AA/NIAAA NIH HHS/United States GR - DA03665/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20040719 PL - United States TA - J Pharmacol Exp Ther JT - The Journal of pharmacology and experimental therapeutics JID - 0376362 RN - 0 (Analgesics, Opioid) RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 76I7G6D29C (Morphine) RN - TE7660XO1C (Glycine) SB - IM MH - Analgesics, Opioid/pharmacology MH - Animals MH - Excitatory Amino Acid Antagonists/pharmacology MH - Glycine/metabolism MH - Morphine/*pharmacology MH - Neurons/*drug effects/metabolism MH - Nucleus Accumbens/*cytology MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors/drug effects/*metabolism EDAT- 2004/07/21 05:00 MHDA- 2004/12/16 09:00 CRDT- 2004/07/21 05:00 PHST- 2004/07/21 05:00 [pubmed] PHST- 2004/12/16 09:00 [medline] PHST- 2004/07/21 05:00 [entrez] AID - jpet.104.067504 [pii] AID - 10.1124/jpet.104.067504 [doi] PST - ppublish SO - J Pharmacol Exp Ther. 2004 Oct;311(1):265-73. doi: 10.1124/jpet.104.067504. Epub 2004 Jul 19.